Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts R. Freeman

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

Analysis of clinical and environmental Candida parapsilosis isolates by microsatellite genotyping—a tool for hospital infection surveillance R. Sabino,

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Cryptococcosis—the impact of delay to diagnosis

Next-generation sequencing technologies and their application to the study and control of bacterial infections J. Besser, H.A. Carleton, P. Gerner-Smidt,

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

Education in infection control: A need for European certification

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient P. Helbling Clinical Microbiology.

Management of post-neurosurgical meningitis: narrative review

Refugee crisis and re-emergence of forgotten infections in Europe

Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study Y. Tagashira,

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? J.-Y. Madec, M. Haenni, P. Nordmann,

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul

The importance of enterovirus surveillance in a Post-polio world

Surveillance of Legionnaires’ disease in Austria

First isolation of Akkermansia muciniphila in a blood-culture sample

Hepatitis C: global epidemiology and strategies for control

Vector control: a cornerstone in the malaria elimination campaign

Update and new insights in encephalitis

Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective J.A. Otter, P. Burgess,

Isospora belli Clinical Microbiology and Infection

Epidemiology of opportunistic infections in AIDS patients

Cutaneous myiasis—a stowaway from Central America

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Symposia and Oral Presentations

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

Thomas G. Heazlewood, Kathryn Ogden, Damhnat McCann

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Vaccinations against respiratory tract infections at Hajj

A.P. Underwood, J. Green Clinical Microbiology and Infection

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

I. Bitar, A. Piazza Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

Virology: a scientific discipline facing new challenges

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

J.L. Balcázar Clinical Microbiology and Infection

CMI editorial report, 2016 Clinical Microbiology and Infection

Molecular history of plague

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

The burden of chikungunya in the Pacific

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts R. Freeman Clinical Microbiology and Infection Volume 22, Issue 10, Pages 896-897 (October 2016) DOI: 10.1016/j.cmi.2016.07.020 Copyright © 2016 Terms and Conditions

Fig. 1 Summary of electronic reporting system (ERS) referral process, data submission and reporting. Clinical Microbiology and Infection 2016 22, 896-897DOI: (10.1016/j.cmi.2016.07.020) Copyright © 2016 Terms and Conditions